HaCaT-ras II-4 Cells

HaCaT-ras II-4 cells are a remarkable and extensively studied cellular model in biological science. These cells are derived from spontaneously immortalized human skin keratinocytes, known as HaCaT cells, which were modified through transfection with the c-Ha-ras (EJ) oncogene. The selection of these cells was based on their resistance to G418, a selective antibiotic, as described in the comprehensive study conducted by Boukamp et al. in 1990.
One notable characteristic of HaCaT-ras II-4 cells is their tumorigenic nature. When these clonal cells are injected into Balb/c-nu/nu mice, they exhibit a fascinating behaviour by forming highly differentiated and locally invasive squamous cell carcinomas. This unique property allows researchers to explore tumour development and progression mechanisms within a controlled experimental environment.
HaCaT-ras II-4 cells are predominantly derived from the Caucasian population, ensuring relevance to a specific ethnic group in scientific investigations. Their origin and characteristics make them an invaluable resource for researchers interested in studying various skin biology and differentiation aspects.
These cells possess a partially to fully differentiated phenotype under typical culture conditions. This phenotype is attributed to the abundant presence of calcium in both traditional media and fetal bovine serum, which provides an ideal environment for the cells to exhibit characteristics resembling those of mature skin cells. This feature allows researchers to investigate the intricate processes involved in skin development, wound healing, and epidermal differentiation.
With their tumorigenic nature and the ability to replicate skin biology in vitro, HaCaT-ras II-4 cells offer a unique opportunity to explore the molecular pathways associated with skin cancer and other skin-related disorders. By utilizing this exceptional cellular model, researchers can gain deeper insights into the underlying mechanisms of tumorigenesis, invasive potential, and therapeutic interventions.
HaCaT-ras II-4 cells are a vital tool for biological science research, specifically in skin biology and differentiation studies. Their origin from spontaneously immortalized human skin keratinocytes, modification with the c-Ha-ras (EJ) oncogene, and subsequent tumorigenic behaviour in mice make them invaluable for investigating skin-related diseases and therapeutic approaches. By harnessing the unique characteristics of HaCaT-ras II-4 cells, researchers can unlock a deeper understanding of skin biology and contribute to advancing medical knowledge and treatment options for various skin disorders.

Adherent

62 years

Caucasian

DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 1.5 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)

Discard Old Medium: Remove the old medium from the flasks.
Wash Cells: Add 3-5 ml of PBS (without calcium and magnesium) to T25 flasks, or 5-10 ml to T75 flasks, to wash the adherent cells.
Add EDTA Solution: Cover the cell layer completely with a freshly prepared 0.05% EDTA solution—use 1-2 ml for T25 flasks and 2.5 ml for T75 flasks.
Incubation: Incubate the flasks at 37 degrees Celsius for 10 minutes.
Add Trypsin/EDTA Solution: Following the incubation, add a freshly prepared trypsin/EDTA solution (0.05% trypsin, 0.025% EDTA) to the flasks, ensuring the cells are fully covered—use 1 ml for T25 flasks and 2.5 ml for T75 flasks.
Monitor Detachment: Observe the cells, which should detach within 1-2 minutes.
Neutralize Trypsin: Add FBS-containing cell culture medium to stop the trypsin activity.
Transfer Cells: Dispense the cell suspension into new flasks pre-filled with fresh culture medium.

CM-1 (Cytion catalog number 800100)

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.
To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Our cells are provided for in vitro laboratory research purposes exclusively and are not intended for clinical or diagnostic use, nor are they to be administered to humans or used for veterinary purposes. Users must adhere to all applicable guidelines and regulations for the handling and use of these cells in a research setting.

X, X

A ratio of 1:5 to 1:10 is recommended

P53 (+), CEA (+),

The 1:1 mixture of EDTA (stock. 0.05%) and trypsin (stock: 0.1%) must be prepared each time ahead of detaching the cells using PBS without Ca2+ and Mg2+ to provide a physiologic osmolarity. Ready-to-use mixtures of trypsin/EDTA are not recommended, as this may result in cell clumps. As an alternative, TrypLETM Express (Life Technologies) instead of trypsin/EDTA can be used. The protocol of the manufacturer should be followed.